Uniqure announces favorable recommendation from independent data monitoring committee for its phase i/ii episod1 clinical trial of amt-162 for the treatment of sod1-als

~ independent data monitoring committee recommends proceeding with dose escalation after planned safety assessment of first dose cohort ~

AMT Ratings Summary

AMT Quant Ranking